Related references
Note: Only part of the references are listed.Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A MetGen Meta-Analysis
T. Dujic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance
P. J. Connelly et al.
DIABETIC MEDICINE (2016)
8. Pharmacologic Approaches to Glycemic Treatment
DIABETES CARE (2016)
Metformin Action: Concentrations Matter
Ling He et al.
CELL METABOLISM (2015)
SLC47A1 gene rs2289669 G > A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients
Rui He et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers
Mette Marie Hougaard Christensen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
M. Joerger et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients
Gurusamy Umamaheswaran et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2015)
Four Cation-Selective Transporters Contribute to Apical Uptake and Accumulation of Metformin in Caco-2 Cell Monolayers
Tianxiang (Kevin) Han et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Association between a gene variant near ataxia telangiectasia mutated and coronary artery disease in men
Stephan Schiekofer et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
The Pharmacogenetics of Type 2 Diabetes: A Systematic Review
Nisa M. Maruthur et al.
DIABETES CARE (2014)
RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population
Y. Zhou et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
Kaixin Zhou et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
Janna K. Duong et al.
CLINICAL PHARMACOKINETICS (2013)
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes
I. Tkac et al.
DIABETES OBESITY & METABOLISM (2013)
Molecular mechanism of action of metformin: old or new insights?
Graham Rena et al.
DIABETOLOGIA (2013)
Pharmacogenetics of Oral Antidiabetic Drugs
Matthijs L. Becker et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
N. van Leeuwen et al.
DIABETOLOGIA (2012)
The role of ATM in response to metformin treatment and activation of AMPK
Angela Woods et al.
NATURE GENETICS (2012)
The role of ATM in response to metformin treatment and activation of AMPK
Sook Wah Yee et al.
NATURE GENETICS (2012)
The role of ATM in response to metformin treatment and activation of AMPK reply
Kaixin Zhou et al.
NATURE GENETICS (2012)
Effects of Genetic Variants Previously Associated with Fasting Glucose and Insulin in the Diabetes Prevention Program
Jose C. Florez et al.
PLOS ONE (2012)
Metformin pathways: pharmacokinetics and pharmacodynamics
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2012)
KCNQ1 variants and response to repaglinide treatment in patients with Type 2 diabetes
Ivan Tkac
PHARMACOGENOMICS (2012)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
Kaixin Zhou et al.
NATURE GENETICS (2011)
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2011)
Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
Kathleen A. Jablonski et al.
DIABETES (2010)
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
Matthijs L. Becker et al.
PHARMACOGENETICS AND GENOMICS (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
Adriaan Kooy et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
Kaixin Zhou et al.
DIABETES (2009)
Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
Matth S. L. Becker et al.
DIABETES (2009)
STrengthening the REporting of Genetic Association studies (STREGA) - an extension of the STROBE statement
Julian Little et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
M. L. Becker et al.
PHARMACOGENOMICS JOURNAL (2009)
HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies
Valentina Porta et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
J Müller et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
MG Wulffelé et al.
DIABETIC MEDICINE (2005)
Combination of insulin and metformin in the treatment of type 2 diabetes
MG Wulffelé et al.
DIABETES CARE (2002)
Share Paper
